Immunome, Inc. (IMNM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 13.15 |
| Open | 13.15 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 12.80 - 13.47 |
| 52-week range | 5.26 - 30.96 |
| Volume | |
| Avg. volume | 809,785 |
| Market cap | 796.387M |
| Beta (5Y monthly) | 1.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Buying: Immunome Inc's CEO Acquires 100,000 Shares
On May 21, 2024, Clay Siegall, President and Chief Executive Officer of Immunome Inc (NASDAQ:IMNM), purchased 100,000 shares of the company, as reported in a recent SEC Filing.
- Zacks
Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Revenue Estimates
Immunome (IMNM) delivered earnings and revenue surprises of 57.50% and 74.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
Immunome (IMNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.